熱門資訊> 正文
Ionis宣布拟议公开发行普通股
2024-09-10 04:28
- Ionis Pharmaceuticals (NASDAQ:IONS) announced a proposed underwritten public offering of $500M of its common stock.
- Ionis intends to grant the underwriters a 30-day option to purchase up to an additional $75M of shares of its common stock offered in the public offering on the same terms and conditions.
- Source: Press Release
More on Ionis Pharmaceuticals
- Ionis Pharmaceuticals: Harnessing RNA-Targeted Therapies For Long-Term Shareholder Value
- Ionis Pharmaceuticals, Inc. (IONS) Q2 2024 Earnings Call Transcript
- Ionis Pharmaceuticals, Inc. (IONS) HALOS Study of ION582 in Angelman Syndrome - (Transcript)
- Biogen announces trial win for higher Spinraza doze
- Ionis Pharmaceuticals GAAP EPS of -$0.45 beats by $0.46, revenue of $225M beats by $75.21M
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
